More importantly, the genome content of UBE2D1 was also higher in precancerous lesions and HCC tissues but not in hepatitis tissues, suggesting that genomic alteration of UBE2D1 may play an important role in carcinogenesis of HCC. Here, UBE2D1 is linked to hepatocellular carcinoma.